Your session is about to expire
← Back to Search
Music Therapy for ICU Delirium (DDM Trial)
N/A
Waitlist Available
Led By Linda Chlan, PhD, RN
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 50 years or older
Admitted to the intensive care unit (medical or surgical)
Must not have
History of dementing illnesses and other neurodegenerative diseases such as Alzheimer's disease or vascular dementia
Any medical condition precluding safe use of headphones such as: skin breakdown, burns, facial or skull fractures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post hospital discharge
Summary
This trial will study whether a seven-day slow-tempo music intervention can decrease delirium/coma free days among mechanically ventilated, critically ill older adults.
Who is the study for?
This trial is for critically ill adults over 50 in the ICU who are expected to need a ventilator for at least 48 hours and can consent through a representative. They must speak English, have phone access, and not have hearing/vision impairments, certain neurological conditions, uncontrolled psychiatric illness, or be at risk of alcohol/drug withdrawal.
What is being tested?
The study tests if slow-tempo music can reduce delirium/coma days in older adults on mechanical ventilation in the ICU. It's a randomized controlled trial where participants either receive attention control or listen to slow-tempo music daily for seven days.
What are the potential side effects?
Since this intervention involves listening to music, side effects are minimal but may include discomfort from wearing headphones or emotional responses to music. The study excludes those with conditions that could make headphone use unsafe.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 50 years old or older.
Select...
I am currently in the ICU.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a history of Alzheimer's or similar memory disorders.
Select...
I don't have conditions that prevent me from safely using headphones.
Select...
I have had a brain injury, stroke, or brain surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months post hospital discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post hospital discharge
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Days free of delirium and coma
Secondary study objectives
Anxiety
Cognition
Delirium Severity
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Slow Tempo MusicExperimental Treatment1 Intervention
Slow-tempo 60-80 beats per minute relaxing music. The intervention includes two one-hour music listening sessions, once in the morning and once in the evening for up to seven days, delivered through noise-canceling headphones and iPad.
Group II: Attention ControlPlacebo Group1 Intervention
One-hour sessions consisting of a silence track twice daily delivered through noise-cancelling headphones for up to 7 days.
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,793 Previous Clinical Trials
28,191,957 Total Patients Enrolled
Indiana UniversityLead Sponsor
1,040 Previous Clinical Trials
1,219,904 Total Patients Enrolled
Linda Chlan, PhD, RNPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
364 Total Patients Enrolled
Babar Khan, MD, MS5.01 ReviewsPrincipal Investigator - Indiana University
Indiana University
1 Previous Clinical Trials
300 Total Patients Enrolled
Media Library
Research Study Groups:
This trial has the following groups:- Group 1: Attention Control
- Group 2: Slow Tempo Music